IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2800
+0.0095 (3.51%)
Apr 8, 2026, 4:00 PM EDT - Market closed
IGC Pharma Market Cap
IGC Pharma has a market cap or net worth of $26.83 million as of April 8, 2026. Its market cap has increased by 4.39% in one year.
Market Cap
26.83M
Enterprise Value
25.85M
1-Year Change
4.39%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since May 24, 2006, IGC Pharma's market cap has decreased from $69.50M to $26.83M, a decrease of -61.40%. That is a compound annual growth rate of -4.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 26.80M | 3.08% |
| Dec 31, 2025 | 26.00M | - |
| Dec 31, 2024 | 26.00M | 46.07% |
| Dec 29, 2023 | 17.80M | 5.33% |
| Dec 30, 2022 | 16.90M | -66.13% |
| Dec 31, 2021 | 49.90M | -22.52% |
| Dec 31, 2020 | 64.40M | 158.63% |
| Dec 31, 2019 | 24.90M | -72.49% |
| Dec 31, 2018 | 90.50M | 222.06% |
| Dec 29, 2017 | 28.10M | 255.70% |
| Dec 30, 2016 | 7.90M | 102.56% |
| Dec 31, 2015 | 3.90M | -58.06% |
| Dec 31, 2014 | 9.30M | 19.23% |
| Dec 31, 2013 | 7.80M | -3.70% |
| Dec 31, 2012 | 8.10M | 32.79% |
| Dec 30, 2011 | 6.10M | -22.78% |
| Dec 31, 2010 | 7.90M | -53.80% |
| Dec 31, 2009 | 17.10M | 101.18% |
| Dec 31, 2008 | 8.50M | -89.66% |
| Dec 31, 2007 | 82.20M | 0.74% |
| Dec 29, 2006 | 81.60M | 17.41% |
| May 24, 2006 | 69.50M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyntra Bio | 28.00M |
| NeuroSense Therapeutics | 26.87M |
| Senti Biosciences | 26.78M |
| Tvardi Therapeutics | 26.74M |
| Passage Bio | 26.35M |
| Daré Bioscience | 25.77M |
| Serina Therapeutics | 25.61M |
| Boundless Bio | 25.54M |